WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gary Charles RobbChief Business Officer2025-12-02148$79.78
$11.81kSell
William GuyerChief Development Officer2025-12-0220,000$21.65
$433.00kBuy
Joseph Douglas LyonChief Accounting Technology Officer2025-12-02110$79.78
$8.78kSell
Atabak MokariChief Financial Officer2025-12-02118$79.78
$9.41kSell
Sean MaduckOfficer2025-12-02135$79.78
$10.77kSell
William GuyerChief Development Officer2025-12-02640$80.88
$51.76kSell
William GuyerChief Development Officer2025-12-0219,360$80.05
$1.55MSell
Gary Charles RobbChief Business Officer2025-12-01224$79.78
$17.87kBuy
William GuyerChief Development Officer2025-12-01224$79.78
$17.87kBuy
Atabak MokariChief Financial Officer2025-12-01178$79.78
$14.20kBuy

1 of 23

CORT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright42.59%44,802,403$3.72BInsider
Blackrock Inc11.45%12,047,830$999.73MInstitution
Bakker Juliet Tammenoms10.54%11,089,541$920.21MInsider
Longitude Venture Partners LP10.42%10,956,002$909.13MInsider
Alta Biopharma Partners II LP9.49%9,982,720$828.37MInsider
Vanguard Group Inc9.07%9,537,071$791.39MInstitution
G. Leonard Baker Jr.8.75%9,200,067$763.42MInsider
Ingalls Snyder LLC7.32%7,697,984$638.78MInstitution
Tench Coxe6.55%6,890,503$571.77MInsider
Joseph C. Cook Jr.6.43%6,765,805$561.43MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT28.45%71.55%Net SellingNet Selling
TECH97.61%2.39%Net BuyingNet Selling
ARWR81.72%10.11%Net SellingNet Selling
ABVX81.93%0.00%
NUVL75.85%24.15%Net SellingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 73.38% institutional shareholders, 184.51% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 42.59% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $3.73B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.